Aimee M. Parow, M.D.



  1. Meeske KA, Patel SK, Palmer SN, Nelson MB, Parow AM. (2007) Factors associated with health-related quality of life in pediatric cancer survivors. Pediatric Blood and Cancer, 49: 298-305.
  2. Carlezon WA Jr, Mague SD, Parow AM, Stoll AL, Cohen BM, Renshaw PF. (2005) Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats. Biological Psychiatry, 57: 343-50.
  3. Rohan M, Parow A, Stoll AL, Demopulos C, Friedman S, Dager S, Hennen J, Cohen BM, Renshaw PF. (2004) Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator. American Journal of Psychiatry, 161: 93-8.
  4. Hirashima F, Parow AM, Stoll AL, Demopulos CM, Damico KE, Rohan ML, Eskesen JG, Zuo CS, Cohen BM, Renshaw PF. (2004) Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder. American Journal of Psychiatry, 161: 1922-4.
  5. Lyoo IK, Kim MJ, Stoll AL, Demopulos CM, Parow AM, Dager SR, Friedman SD, Dunner DL, Renshaw PF. (2004) Frontal lobe gray matter density decreases in bipolar I disorder. Biological Psychiatry, 55: 648-51.
  6. Friedman SD, Dager SR, Parow A, Hirashima F, Demopulos C, Stoll AL, Lyoo IK, Dunner DL, Renshaw PF. (2004) Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biological Psychiatry, 56: 340-8.
  7. Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, Dunner DL, Renshaw PF. (2004) Brain metabolic alterations in medication-free patients with bipolar disorder. Archives of General Psychiatry, 61: 450-8.
  8. Ke Y, Streeter C, Lowen S, Nassar LE, Parow AM, Hennen J, Yurgelun-Todd DA, Sarid-Segal O, Awad LA, Rendall M, Gruber SA, Nason A, Mudrick MJ, Blank SR, Ciraulo DA, Renshaw PF. (2003) Increased frontal lobe phosphocreatine levels observed in heavy cocaine users after treatment for cocaine dependence-An 1H MRS T2 relaxometry study. Spectroscopy, 17: 231 Aimee M. Parow, MD 1/2/13 Page 4 of 6 39.
  9. Lyoo IK, Kong SW, Sung SM Hirashima F, Parow A, Hennen J, Cohen BM, Renshaw PF. (2003) Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate. Psychiatry Research, 123: 87-100.
  10. Dorsey CM, Lukas SE, Moore CM, Tartarini WL, Parow AM, Villafuerte RA, Renshaw PF.  (2003) Phosphorus31 magnetic resonance spectroscopy after total sleep deprivation in healthy adult men. Sleep, 26: 573-7.
  11. Silveri MM, Parow AM, Villafuerte RA, Damico KE, Goren J, Stoll AL, Cohen BM, Renshaw PF. (2003) S-adenosyl-L-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects. Biological Psychiatry, 54: 833-9.
  12. Carlezon WA, Pliakas AM, Parow AM, Detke MJ, Cohen BM, Renshaw PF, (2002) Antidepressant-like effects of cytidine in the forced swim test in rats. Biological Psychiatry, 51: 882-889.
  13. Renshaw PF, Parow AM, (2001) Psychiatric Disease, in Magnetic Resonance Imaging of the Brain and Spine. 3rd Edition Ed. Scott Atlas, Lippincott Williams & Wilkins, NY, NY, 1993-2019.
  14. Renshaw PF, Parow AM, Hirashima F, Ke Y, Moore CM, Frederick BdeB, Fava M, Babb SM, Hennen J, (2001) Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression. Am J Psychiatry, 158: 2048-2055.
  15. Parow, AM, (1999) The role of NMDA receptors in female sexual behavior in hamsters. Tufts University Archives.

Back to topBack To Top